RecruitingNCT05937477

Developing Artificial Intelligence-based Algorism to Predict Side Effects and Symptoms From Chemotherapy

Developing Artificial Intelligence-based Algorism Based on Life-log Data Acquired From Wearable Device for the Prediction of Chemotherapy-induced Side Effects and Symptom

Sponsor

Sehhoon Park

Enrollment

500 participants

Start Date

Jun 8, 2023

Study Type

OBSERVATIONAL

Conditions

Esophageal Cancer Lung Cancer Head and Neck Cancer

Summary

In this study, the investigators obtain wearable disease based biomarkers from patients diagnosed with cancer and undergoing chemotherapy, and simultaneously measure patient self-reported adverse events through an app to evaluate chemotherapy completion rates, emergency room visits, and frequency of CTCAE adverse events. The investigators will develop an artificial intelligence-based algorism that can predict patients' side effects based on biomarkers alone.

Eligibility

Min Age: 20 Years

Plain Language Summary

Simplified for easier understanding

This study is building an AI system to predict side effects and symptoms that cancer patients may experience during chemotherapy, using data collected through a smartphone app. **You may be eligible if...** - You are 20 years of age or older - You have been diagnosed with lung, head and neck, or esophageal cancer - You are starting your first chemotherapy treatment (before or after surgery, or for recurrent/spread cancer) - You are well enough to carry out daily activities (ECOG 0–2) - You own a smartphone and can use a mobile app on your own **You may NOT be eligible if...** - You do not have one of the qualifying cancer types - You have already received chemotherapy previously - You are too unwell to use a smartphone or participate regularly Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERFitbit smartwatch

Patients wear the wearable to check their biomarkers and use the application to assess their quality of life and side effects at one-week intervals.

Locations(1)

Samsung Medical Center

Seoul, Gangnamgu, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05937477

Related Trials

Tongue Proactive Strengthening Exercise Program Following Partial/Hemi Glossectomy and Reconstruction

NCT071101421 location

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

NCT0661828764 locations

Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer Treatment

NCT060473011 location

Lung Cancer Biomarkers and Screening

NCT003011191 location

A Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal Cancer: PALEO Study

NCT062905059 locations